PubMed:10491412
Annnotations
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 0-20 | DiseaseOrPhenotypicFeature | denotes | Renal cell carcinoma | 0005086|0005549 |
| T3 | 210-231 | DiseaseOrPhenotypicFeature | denotes | renal cell carcinomas | 0005086|0005549 |
| T5 | 233-237 | DiseaseOrPhenotypicFeature | denotes | RCCs | 0005086 |
| T6 | 294-298 | DiseaseOrPhenotypicFeature | denotes | RCCs | 0005086 |
| T7 | 482-485 | DiseaseOrPhenotypicFeature | denotes | RCC | 0005086|0005549|0007763|0044874 |
| T11 | 726-737 | DiseaseOrPhenotypicFeature | denotes | sensitivity | 0000605 |
| T12 | 891-894 | DiseaseOrPhenotypicFeature | denotes | RCC | 0005086|0005549|0007763|0044874 |
| T16 | 975-978 | DiseaseOrPhenotypicFeature | denotes | RCC | 0005086|0005549|0007763|0044874 |
| T20 | 1205-1210 | DiseaseOrPhenotypicFeature | denotes | tumor | 0005070 |
| T21 | 1286-1290 | DiseaseOrPhenotypicFeature | denotes | RCCs | 0005086 |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 210-231 | HP_0005584 | denotes | renal cell carcinomas |
| T2 | 437-442 | HP_0002664 | denotes | Tumor |
| T3 | 1205-1210 | HP_0002664 | denotes | tumor |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 51-72 | protein | denotes | nuclear factor-kappaB |
| T2 | 87-94 | cell_type | denotes | T cells |
| T3 | 114-156 | protein | denotes | transcription factor nuclear factor-kappaB |
| T4 | 158-166 | protein | denotes | NFkappaB |
| T5 | 183-190 | cell_type | denotes | T cells |
| T6 | 255-262 | cell_type | denotes | T cells |
| T7 | 319-327 | protein | denotes | NFkappaB |
| T8 | 404-422 | protein | denotes | cytoplasmic factor |
| T9 | 423-435 | protein | denotes | IkappaBalpha |
| T10 | 437-467 | protein | denotes | Tumor-derived soluble products |
| T11 | 503-511 | protein | denotes | NFkappaB |
| T12 | 524-531 | cell_type | denotes | T cells |
| T13 | 600-612 | protein | denotes | IkappaBalpha |
| T14 | 741-754 | protein | denotes | neuraminidase |
| T15 | 763-771 | protein | denotes | protease |
| T16 | 891-903 | cell_type | denotes | RCC explants |
| T17 | 1066-1074 | protein | denotes | NFkappaB |
| T18 | 1095-1102 | cell_type | denotes | T cells |
| T19 | 1133-1142 | protein | denotes | cytokines |
| T20 | 1143-1147 | protein | denotes | IL-2 |
| T21 | 1152-1161 | protein | denotes | IFN-gamma |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-95 | Sentence | denotes | Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. |
| S2 | 96-239 | Sentence | denotes | Activation of the transcription factor nuclear factor-kappaB (NFkappaB) is impaired in T cells from patients with renal cell carcinomas (RCCs). |
| S3 | 240-436 | Sentence | denotes | In circulating T cells from a subset of patients with RCCs, the suppression of NFkappaB binding activity is downstream from the stimulus-induced degradation of the cytoplasmic factor IkappaBalpha. |
| S4 | 437-640 | Sentence | denotes | Tumor-derived soluble products from cultured RCC explants inhibit NFkappaB activity in T cells from healthy volunteers, despite a normal level of stimulus-induced IkappaBalpha degradation in these cells. |
| S5 | 641-836 | Sentence | denotes | The inhibitory agent has several features characteristic of a ganglioside, including sensitivity to neuraminidase but not protease treatment; hydrophobicity; and molecular weight less than 3 kDa. |
| S6 | 837-947 | Sentence | denotes | Indeed, we detected gangliosides in supernatants from RCC explants and not from adjacent normal kidney tissue. |
| S7 | 948-1162 | Sentence | denotes | Gangliosides prepared from RCC supernatants, as well as the purified bovine gangliosides G(m1) and G(d1a), suppressed NFkappaB binding activity in T cells and reduced expression of the cytokines IL-2 and IFN-gamma. |
| S8 | 1163-1291 | Sentence | denotes | Taken together, our findings suggest that tumor-derived gangliosides may blunt antitumor immune responses in patients with RCCs. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 87-94 | NP | denotes | T cells |
| C2 | 196-238 | NP | denotes | patients with renal cell carcinomas (RCCs) |
| C3 | 280-298 | NP | denotes | patients with RCCs |
| C4 | 437-494 | NP | denotes | Tumor-derived soluble products from cultured RCC explants |
| C5 | 628-639 | NP | denotes | these cells |
| C6 | 641-661 | NP | denotes | The inhibitory agent |
| C7 | 1095-1102 | NP | denotes | T cells |
| C8 | 1272-1290 | NP | denotes | patients with RCCs |
| R1 | C3 | C2 | coref-ident | patients with RCCs,patients with renal cell carcinomas (RCCs) |
| R2 | C5 | C1 | coref-ident | these cells,T cells |
| R3 | C6 | C4 | coref-ident | The inhibitory agent,Tumor-derived soluble products from cultured RCC explants |
| R4 | C7 | C5 | coref-ident | T cells,these cells |
| R5 | C8 | C3 | coref-ident | patients with RCCs,patients with RCCs |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-41 | other_organic_compound | denotes | Renal cell carcinoma-derived gangliosides |
| T2 | 51-72 | protein_complex | denotes | nuclear factor-kappaB |
| T3 | 87-94 | cell_type | denotes | T cells |
| T4 | 114-156 | protein_complex | denotes | transcription factor nuclear factor-kappaB |
| T5 | 158-166 | protein_complex | denotes | NFkappaB |
| T6 | 183-190 | cell_type | denotes | T cells |
| T7 | 196-204 | multi_cell | denotes | patients |
| T8 | 210-231 | tissue | denotes | renal cell carcinomas |
| T9 | 233-237 | tissue | denotes | RCCs |
| T10 | 255-262 | cell_type | denotes | T cells |
| T11 | 280-288 | multi_cell | denotes | patients |
| T12 | 294-298 | tissue | denotes | RCCs |
| T13 | 319-327 | protein_complex | denotes | NFkappaB |
| T14 | 368-396 | other_name | denotes | stimulus-induced degradation |
| T15 | 404-422 | protein_family_or_group | denotes | cytoplasmic factor |
| T16 | 423-435 | protein_molecule | denotes | IkappaBalpha |
| T17 | 437-467 | protein_family_or_group | denotes | Tumor-derived soluble products |
| T18 | 473-485 | tissue | denotes | cultured RCC |
| T19 | 503-511 | protein_complex | denotes | NFkappaB |
| T20 | 524-531 | cell_type | denotes | T cells |
| T21 | 537-555 | multi_cell | denotes | healthy volunteers |
| T22 | 583-599 | other_name | denotes | stimulus-induced |
| T23 | 600-612 | protein_molecule | denotes | IkappaBalpha |
| T24 | 703-714 | other_organic_compound | denotes | ganglioside |
| T25 | 741-754 | protein_molecule | denotes | neuraminidase |
| T26 | 763-771 | protein_family_or_group | denotes | protease |
| T27 | 783-797 | other_name | denotes | hydrophobicity |
| T28 | 857-869 | other_organic_compound | denotes | gangliosides |
| T29 | 891-903 | cell_type | denotes | RCC explants |
| T30 | 926-946 | tissue | denotes | normal kidney tissue |
| T31 | 948-960 | other_organic_compound | denotes | Gangliosides |
| T32 | 975-991 | cell_component | denotes | RCC supernatants |
| T33 | 1008-1023 | other_organic_compound | denotes | purified bovine |
| T34 | 1024-1036 | other_organic_compound | denotes | gangliosides |
| T35 | 1066-1074 | protein_complex | denotes | NFkappaB |
| T36 | 1095-1102 | cell_type | denotes | T cells |
| T37 | 1133-1142 | protein_family_or_group | denotes | cytokines |
| T38 | 1143-1147 | protein_molecule | denotes | IL-2 |
| T39 | 1152-1161 | protein_molecule | denotes | IFN-gamma |
| T40 | 1205-1218 | other_organic_compound | denotes | tumor-derived |
| T41 | 1219-1231 | other_organic_compound | denotes | gangliosides |
| T42 | 1242-1268 | other_name | denotes | antitumor immune responses |
| T43 | 1272-1280 | multi_cell | denotes | patients |
| T44 | 1286-1290 | tissue | denotes | RCCs |